Condition
Sclerotherapy
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Recruiting2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07481617Not Yet Recruiting
Laparoscopic Sclerotherapy for the Management of Ovarian Endometriomas
NCT07678697Not ApplicableRecruiting
Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique
NCT05962775Not ApplicableRecruiting
Ethanol Sclerotherapy Prior to ART
NCT06274086Not ApplicableCompletedPrimary
Two-session Catheter-directed Sclerotherapy Using Ethanol for Endometrioma
NCT04132323Not ApplicableCompletedPrimary
Low Concentrate Detergents Versus Hypertonic Glucose for the Treatment of Telangiectasia
Showing all 5 trials